Medicare Enrolled

Dr. Nestor Almeida, MD

Nephrology · Cordele, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
106 W 4TH AVE, Cordele, GA 31015
2292713200
In practice since 2011 (15 years)
NPI: 1891089926 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Almeida from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Almeida? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Almeida

Dr. Nestor Almeida is a nephrology specialist in Cordele, GA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Almeida performed 102 Medicare services across 84 unique beneficiaries.

Between the years covered by Open Payments, Dr. Almeida received a total of $13,835 from 40 pharmaceutical and/or device companies across 370 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Almeida is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ 102 Medicare services $13,835 industry payments

Medicare Practice Summary

Medicare Utilization ↗
102
Medicare services
Bottom 4% in GA for nephrology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
84
Unique beneficiaries
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~7 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
32 $43 $212
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
22 $8 $100
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $88 $428
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $62 $302
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
13 $2 $34
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,835
Total received (2018-2024)
Avg $1,976/year across 7 years
Top 7% in GA for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
370
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,177 (59.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,658 (40.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$738
2023
$515
2022
$1,152
2021
$1,021
2020
$4,813
2019
$1,120
2018
$4,477

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$117
Bayer Healthcare Pharmaceuticals Inc.
$97
Otsuka America Pharmaceutical, Inc.
$89
Travere Therapeutics, Inc.
$85
Aurinia Pharma U.S., Inc.
$84
Fresenius USA Marketing, Inc.
$80
Ardelyx, Inc.
$72
Amgen Inc.
$44
Lilly USA, LLC
$41
Novartis Pharmaceuticals Corporation
$16
GlaxoSmithKline, LLC.
$13
Top 3 companies account for 41.0% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$5,320
Horizon Pharma plc
$3,628
Amgen Inc.
$858
AstraZeneca Pharmaceuticals LP
$496
Bayer Healthcare Pharmaceuticals Inc.
$340
Travere Therapeutics, Inc.
$307
OPKO Pharmaceuticals, LLC
$288
GlaxoSmithKline, LLC.
$279
Horizon Therapeutics plc
$243
Shire North American Group Inc
$192
Exeltis, USA Inc.
$174
Alexion Pharmaceuticals, Inc.
$167
Bayer HealthCare Pharmaceuticals Inc.
$165
Mallinckrodt Hospital Products Inc.
$147
Relypsa, Inc.
$132
Fresenius USA Marketing, Inc.
$120
Vifor Pharma, Inc.
$118
Takeda Pharmaceuticals U.S.A., Inc.
$96
Aurinia Pharma U.S., Inc.
$84
CALLIDITAS THERAPEUTICS US INC.
$82
Ardelyx, Inc.
$72
Octapharma USA, Inc.
$66
Alnylam Pharmaceuticals Inc.
$50
Retrophin, Inc.
$45
Lilly USA, LLC
$41
Novartis Pharmaceuticals Corporation
$40
Mallinckrodt LLC
$33
Calliditas Therapeutics US Inc.
$31
GENZYME CORPORATION
$29
Novo Nordisk Inc
$25
Daiichi Sankyo Inc.
$23
Terumo BCT, Inc.
$22
Merck Sharp & Dohme LLC
$20
Otsuka Pharmaceutical Development & Commercialization, Inc.
$18
Allergan Inc.
$16
Mallinckrodt Enterprises LLC
$15
Keryx Biopharmaceuticals, Inc.
$14
Janssen Pharmaceuticals, Inc
$14
AKEBIA THERAPEUTICS INC
$13
Mission Pharmacal Company
$12
Top 3 companies account for 70.9% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ACTHAR · AFINITOR · AURYXIA · Aquoral · Auryxia · BELSOMRA · BENLYSTA · BYSTOLIC · FABRY-DISEASE · FARXIGA · Fabhalta · GATTEX · IBSRELA · INJECTAFER · INVOKANA · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · OCTAPLAS · OXLUMO · Ozempic · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rayaldee · Repatha · SAMSCA · SOLIRIS · TARPEYO · THYMOGLOBULIN · Thiola · Tresiba · ULTOMIRIS · Ultomiris · Velphoro · Veltassa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (59%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nephrology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for nephrology in GA.

Looking for a nephrology specialist in Cordele?
Compare nephrologists in the Cordele area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
3
Per 100K population
15.0
County median income
$42,745
Nearest hospital
CRISP REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Almeida is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 7% of GA peers, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Almeida experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Almeida performed 32 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Almeida receive payments from pharmaceutical companies?
Yes. Dr. Almeida received a total of $13,835 from 40 companies across 370 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Almeida's costs compare to other nephrologists in Cordele?
Dr. Almeida's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Almeida) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →